HOME >> BIOLOGY >> NEWS
Researchers Find Possible New Route to Making Cancer Cells Vulnerable

DURHAM, N.C. -- Researchers at the Howard Hughes Medical Institute at Duke University Medical Center have shown how drugs that stop organ transplant rejection also partially reverse drug resistance in certain cancer cells.

Such resistance, which thwarts cancer chemotherapy, is a principal cause of death for cancer patients. The scientists have identified a new target to stop drug resistance in cancer cells. The researchers believe the finding will help scientists develop new compounds to prevent drug resistance in patients with cancer, but without compromising the immune system.

"We may have identified an Achilles' heel in the body's natural reaction in expelling toxic drugs," said geneticist Dr. Joseph Heitman, the study's principal investigator.

The research was supported in part by the National Institute of Environmental Health Sciences and a Rhone Poulenc Rorer Hematology Scholar award to colleague Dr. Charles Hemenway.

Heitman and Hemenway, both researchers in Duke's Comprehensive Cancer Center, reported their findings in the Aug. 2 issue of the Journal of Biological Chemistry. They found that three drugs given to stop organ transplant rejection -- cyclosporin, FK506, and rapamycin -- also block the cellular pump that expels cancer chemotherapy drugs. But it turns out the drugs block the pump by different mechanisms.

Previously, scientists believed the anti-rejection drugs acted like sludge in a gas tank, clogging the pump mechanism. But the Duke scientists showed that FK506 and rapamycin also tie up a separate protein, called FKBP12, which they showed is an essential activator for the pump to work correctly. In other words, the two drugs primarily halt the cellular pump by removing a vital part, like a valve from a car's fuel pump.

"Cyclosporin-related drugs are now being tested for their ability to reverse chemotherapy resistance in cancer patients, but little
'"/>

Contact: Karyn Hede George
georg016@mc.duke.edu
919-660-1301
Duke University
2-Aug-1996


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... , ... November 20, 2019 , ... BioInformatics Inc., part ... science tools market, today announced the winners of the Life Science Industry Awards for ... the Life Science Industry Awards – Innovation: , Most Innovative New Product – Cell ...
(Date:11/19/2019)... ... November 19, 2019 , ... Diagenode, Inc., ... Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science ... offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, to help ...
(Date:11/19/2019)... ... ... Hosted at the Las Vegas Convention Center, and brought to you by ... of MJBiz business professionals in the world. With over 1,300 exhibitors from more than ... show quite like it. Atlantic Ultraviolet will exhibit at Booth C9217, showcasing its ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... N.C. (PRWEB) , ... December 03, 2019 , ... A ... studies have shown can reduce and even reverse fibrosis (scar tissue) buildup – also ... at Stanford University School of Medicine, was conducted on mice. , The tumor-destroying ...
(Date:11/22/2019)... ... November 22, 2019 , ... Modality Solutions, ... cold chain validation guide to meet and exceed increasingly stringent regulatory expectations ... biopharmaceutical industry leaders, the September 19, 2019 webinar was well received and ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies , ... Genedata Biologics® to streamline their R&D operations related to the ...
(Date:11/6/2019)... ... 2019 , ... Diversified Technologies, Inc. has introduced a PEF production ... to improve processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of ... yields by up to 50% and achieve up to an 80% reduction of drying ...
Breaking Biology Technology:
Cached News: